Researchers have developed and validated an experimental compound, FLAV-27, capable of reversing #cognitive decline in Alzheimer's disease by reprogramming the neuronal epigenome to correct altered gene expression rather than merely clearing amyloid plaques.
#Neuropharmacology #Epigenetics #Neuroscience #sflorg
https://www.sflorg.com/2026/03/pharm03142601.html